Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation

Author： Wheeler Heather E   Dolan M Eileen  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.1, 2012-01, pp. : 55-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Lymphoblastoid cell lines in pharmacogenomics: how applicable are they to clinical outcomes?

By Stark Amy L   Dolan M Eileen  

Pharmacogenomics, Vol. 14, Iss. 5, 2013-04 ,pp. : 447-450

Future Medicine

Access to resources Recommend Favorite

Human lymphoblastoid cell lines: a goldmine for the biobankomics era

By Nam Hye-Young   Shim Sung-Mi   Han Bok-Ghee   Jeon Jae-Pil  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 907-917

Future Medicine

Access to resources Recommend Favorite

Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations

By Vincent Marc   Oved Keren   Morag Ayelet   Pasmanik-Chor Metsada   Oron-Karni Varda   Shomron Noam   Gurwitz David  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1893-1904

Future Medicine

Access to resources Recommend Favorite

Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers

By Oved Keren   Morag Ayelet   Pasmanik-Chor Metsada   Oron-Karni Varda   Shomron Noam   Rehavi Moshe   Stingl Julia C   Gurwitz David  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1129-1139

Future Medicine

Access to resources Recommend Favorite

Approaches to the discovery of pharmacogenomic markers in oncology: 2000–2010–2020

By Huang R Stephanie   Dolan M Eileen  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 471-474

Future Medicine

Access to resources Recommend Favorite